Cargando…
IL-27 Promotes Proliferation of Human Leukemic Cell Lines Through the MAPK/ERK Signaling Pathway and Suppresses Sensitivity to Chemotherapeutic Drugs
IL-27 is a pleiotropic cytokine of the IL-6/IL-12 family with diverse biological functions. Previous in vivo studies have suggested the antitumor activities of IL-27 in animal models, whereas clinical observations indicate the link of IL-27 in tumor progression. IL-27 has recently been shown to caus...
Autores principales: | Jia, Haiyan, Dilger, Paula, Bird, Chris, Wadhwa, Meenu |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Mary Ann Liebert, Inc.
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4854210/ https://www.ncbi.nlm.nih.gov/pubmed/27119567 http://dx.doi.org/10.1089/jir.2015.0091 |
Ejemplares similares
-
Severity of the TGN1412 trial disaster cytokine storm correlated with IL-2 release
por: Eastwood, David, et al.
Publicado: (2013) -
Effect of GINS2 on Proliferation and Apoptosis in Leukemic Cell Line
por: Zhang, Xi, et al.
Publicado: (2013) -
GPR27 Regulates Hepatocellular Carcinoma Progression via MAPK/ERK Pathway
por: Wang, Hongxv, et al.
Publicado: (2022) -
ERK3/MAPK6 controls IL-8 production and chemotaxis
por: Bogucka, Katarzyna, et al.
Publicado: (2020) -
Synergistic interactions of cytarabine-adavosertib in leukemic cell lines proliferation and metabolomic endpoints
por: Rodríguez-Vázquez, Gabriel O., et al.
Publicado: (2023)